This invention relates to crystalline forms of (R)-1-(1-(methylsulfonyl)propan-2-yl)-4-(trifluoromethyl)indoline-5-carbonitrile, a modulator of the androgen receptor, and methods for the use in treatment.
这项发明涉及(R)-1-(1-(甲磺氧基)丙基)-4-(三
氟甲基)
吲哚-5-羧腈的晶体形式,这是一种雄激素受体调节剂,并且涉及在治疗中的使用方法。